Beauty Health (NASDAQ:SKIN) Price Target Raised to $1.75

Beauty Health (NASDAQ:SKIN) had its price objective increased by Canaccord Genuity Group from $1.25 to $1.75 in a report released on Wednesday,Benzinga reports. They currently have a hold rating on the stock.

Other equities analysts have also recently issued reports about the stock. Stifel Nicolaus cut their target price on shares of Beauty Health from $4.00 to $2.00 and set a “hold” rating for the company in a research note on Friday, July 26th. Piper Sandler reiterated an “underweight” rating and set a $1.00 target price (down from $1.50) on shares of Beauty Health in a research note on Friday, August 9th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $2.55.

Beauty Health Price Performance

Shares of Beauty Health stock opened at $1.53 on Wednesday. The firm has a fifty day simple moving average of $1.57 and a 200-day simple moving average of $1.88. The company has a debt-to-equity ratio of 9.23, a quick ratio of 5.47 and a current ratio of 6.56. Beauty Health has a 1-year low of $0.91 and a 1-year high of $5.17.

Institutional Trading of Beauty Health

A number of hedge funds have recently modified their holdings of SKIN. Barclays PLC increased its stake in Beauty Health by 224.7% during the 3rd quarter. Barclays PLC now owns 106,103 shares of the company’s stock worth $153,000 after purchasing an additional 73,425 shares in the last quarter. Orion Portfolio Solutions LLC bought a new stake in Beauty Health during the 3rd quarter worth approximately $65,000. Jacobs Levy Equity Management Inc. increased its stake in Beauty Health by 1.1% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 2,499,652 shares of the company’s stock worth $3,599,000 after purchasing an additional 27,665 shares in the last quarter. HighTower Advisors LLC bought a new stake in Beauty Health during the 3rd quarter worth approximately $121,000. Finally, Atom Investors LP increased its stake in Beauty Health by 19.7% during the 3rd quarter. Atom Investors LP now owns 99,924 shares of the company’s stock worth $144,000 after purchasing an additional 16,416 shares in the last quarter. 93.26% of the stock is currently owned by institutional investors and hedge funds.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.